Dr Lenze of Washington University St. Louis Talks Antidepressant Fluvoxamine Covid-19 Clinical Trial
3 years ago
5
Dr. Lenze discusses a clinical trial conducted by Washington University School of Medicine in St. Louis which evidences the potential that fluvoxamine, an antidepressant, may prevent COVID-19 infections from worsening. This trial is based on recent research that originates from the University of Virginia School of Medicine.
Website: https://stopcovidtrial.wustl.edu/
Phone: 314-747-1137
Email: stopcovidtrial@wustl.edu
Loading comments...
-
20:19
The Jimmy Dore Show
1 year agoFluvoxamine Showed AMAZING RESULTS Against COVID, So What Happened?
3.76K24 -
3:11
One America News Network
2 years agoDr. Marik: Doctors are targeted for prescribing off label meds for COVID-19
2.91K25 -
0:32
Newsy
2 years agoCheap Antidepressant Shows Promise Treating Early COVID-19
7756 -
0:47
Western Standard
1 year agoU of C study finds antibiotics can be used to treat depression...
59 -
45:42
CarlosLowenbrau
1 year agoDr. Simone Gold & Frontline Doctors Discuss COVID (07/28/2020)
34 -
57:01
Four Corner Ministries News through a Christian Filter
1 year ago2022 JUL 22 ACTIV-6 COVID 19 Study of Repurposed Medications [MEDICAL STUDY PRESENTATION]
169 -
5:00
Biological Medicine
1 year agoExisting drug that can treat COVID-19 infections
2488 -
24:53
UnitedHealthAlliance
1 year ago4. CLINICAL TRIAL, USING CDS TO TREAT COVID-19, HIGHLY SUCCESSFUL AT ALL STAGES!
60 -
10:39
PeteMcArthur
1 year agoCPSO Recommends "medications...referral to psychotherapy" For Those Not Wanting Covid Vax
13 -
6:57
Effective Covid Treatments
1 year agoAnother Covid treatment suppressed - fluvoxamine
32